Skip to main content
. 2023 May 23;11(6):1019. doi: 10.3390/vaccines11061019

Figure 2.

Figure 2

Figure 2

Neutralization activity of SARS-CoV-2 spike variants by plasma. D0, before booster vaccination; D14, 14 days after booster vaccination; D28, 28 days after booster vaccination; M3, 3 months after booster vaccination; M6, 6 months after booster vaccination. The longer horizontal line represents the median neutralizing antibody titers and the horizontal lines at the ends represent the quartiles of neutralizing antibodies titers. Dots indicate the neutralizing antibody titer for each participant, and dots outside the shorte horizontal line indicate dots beyond 1.5 times the IQR. (A) The neutralizing antibody levels of PLWH against BA.5 strain before the third vaccination and 14 days, 28 days, 3 months, and 6 months after the vaccination. (B) The levels of neutralizing antibodies detected in PLWH against BF.7 before and 14 days, 28 days, 3 months, and 6 months after the third vaccination. (C) The levels of neutralizing antibodies detected in PLWH against Delta strain before and 14 days, 28 days, 3 months, and 6 months after the third vaccination. (D) The levels of neutralizing antibodies detected in PLWH against the D614G strain before the third vaccination and 14 days, 28 days, 3 months, and 6 months after the vaccination. (E) The level of neutralizing antibodies against BA.5, BF.7, Delta, and D614G about 14 days after PLWH booster vaccination. (F) The neutralizing antibody levels against BA.5, BF.7, Delta, and D614G about 28 days after PLWH booster vaccination. (G) The neutralizing antibody levels against BA.5, BF.7, Delta, and D614G about 3 months after PLWH booster vaccination.